FDA Adverse Event
Injury
Summary report: N
GORE EXCLUDER AAA ENDOPROSTHESIS
MDR report key: 2921926
·
Received January 11, 2013
Report
- Report Number
- 2017233-2013-00017
- Event Type
- Injury
- Date Received
- January 11, 2013
- Date of Event
- December 14, 2012
- Report Date
- December 20, 2012
- Manufacturer
- W.L. GORE & ASSOCIATES
- Product Code
- MIH
- PMA / PMN Number
- P020004
- Report Source
- Manufacturer report
- Reporter Location
- IL, US
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
THE REVIEW OF THE MFG PAPERWORK VERIFIED THAT THIS LOT MET ALL PRE-RELEASE SPECIFICATIONS. ADDITIONAL DEVICES IMPLANTED AND INVOLVED IN THIS EVENT: PXC201000/7367340 AND PXC181200/06171053.
Description of Event or Problem · 1
ON (B)(6) 2012, THE PT UNDERWENT TREATMENT OF AN ABDOMINAL AORTIC ANEURYSM WITH THREE GORE EXCLUDER AAA ENDOPROSTHESES. IT WAS REPORTED THAT ON (B)(6) 2012, F/U IMAGING IDENTIFIED A TYPE II ENDOLEAK FROM A LUMBAR ARTERY WITH ANEURYSM ENLARGEMENT FROM 5 TO 5.5 CM. NO FURTHER ADVERSE EVENTS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 18092 | GORE EXCLUDER AAA ENDOPROSTHESIS | MIH / SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT | MIH | W.L. GORE & ASSOCIATES | 06670904 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 79 YR | Hospitalization| R | SIMVASTATIN| LEVOTHYROXINE SODIUM| ADVAIR| AMLODIPINE| ASPIRIN| ENALAPRIL |